Antitargets: prediction and prevention of drug side effects
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Weinheim
Wiley-VCH
©2008
|
| Schriftenreihe: | Methods and principles in medicinal chemistry
v. 38 |
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 Volltext |
| Beschreibung: | Includes bibliographical references and index This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that may be used as guidelines on how to improve drug development projects. With its large section on ADME-related effects, this is key knowledge for every drug developer |
| Beschreibung: | 1 Online-Ressource (xxiv, 480 pages) |
| ISBN: | 9783527621460 3527621466 9783527621477 3527621474 1282784307 9781282784307 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043388752 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 9783527621460 |9 978-3-527-62146-0 | ||
| 020 | |a 3527621466 |9 3-527-62146-6 | ||
| 020 | |a 9783527621477 |c electronic bk. |9 978-3-527-62147-7 | ||
| 020 | |a 3527621474 |c electronic bk. |9 3-527-62147-4 | ||
| 020 | |a 1282784307 |9 1-282-78430-7 | ||
| 020 | |a 9781282784307 |9 978-1-282-78430-7 | ||
| 024 | 7 | |a 10.1002/9783527621460 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn264389537 | ||
| 035 | |a (OCoLC)264389537 | ||
| 035 | |a (DE-599)BVBBV043388752 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 615.704 |2 22 | |
| 245 | 1 | 0 | |a Antitargets |b prediction and prevention of drug side effects |c edited by Roy J. Vaz and Thomas Klabunde |
| 264 | 1 | |a Weinheim |b Wiley-VCH |c ©2008 | |
| 300 | |a 1 Online-Ressource (xxiv, 480 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods and principles in medicinal chemistry |v v. 38 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that may be used as guidelines on how to improve drug development projects. With its large section on ADME-related effects, this is key knowledge for every drug developer | ||
| 650 | 4 | |a Pharmaceutical Preparations / adverse effects | |
| 650 | 4 | |a Cytochrome P-450 Enzyme System | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Drug Interactions | |
| 650 | 4 | |a Ion Channels | |
| 650 | 4 | |a Receptors, G-Protein-Coupled | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drugs / Side effects | |
| 650 | 4 | |a Drugs / Side effects / Prevention | |
| 650 | 4 | |a Drug interactions | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs / Structure-activity relationships | |
| 650 | 0 | 7 | |a Pharmazeutische Chemie |0 (DE-588)4132158-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | 1 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 1 | 1 | |a Pharmazeutische Chemie |0 (DE-588)4132158-3 |D s |
| 689 | 1 | |8 3\p |5 DE-604 | |
| 700 | 1 | |a Vaz, Roy J. |e Sonstige |4 oth | |
| 700 | 1 | |a Klabunde, Thomas |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028807336 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175960788959232 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043388752 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn264389537 (OCoLC)264389537 (DE-599)BVBBV043388752 |
| dewey-full | 615.704 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.704 |
| dewey-search | 615.704 |
| dewey-sort | 3615.704 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03622nmm a2200769zcb4500</leader><controlfield tag="001">BV043388752</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527621460</subfield><subfield code="9">978-3-527-62146-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527621466</subfield><subfield code="9">3-527-62146-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527621477</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-3-527-62147-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527621474</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">3-527-62147-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282784307</subfield><subfield code="9">1-282-78430-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282784307</subfield><subfield code="9">978-1-282-78430-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9783527621460</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn264389537</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)264389537</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043388752</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.704</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antitargets</subfield><subfield code="b">prediction and prevention of drug side effects</subfield><subfield code="c">edited by Roy J. Vaz and Thomas Klabunde</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim</subfield><subfield code="b">Wiley-VCH</subfield><subfield code="c">©2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxiv, 480 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods and principles in medicinal chemistry</subfield><subfield code="v">v. 38</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that may be used as guidelines on how to improve drug development projects. With its large section on ADME-related effects, this is key knowledge for every drug developer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations / adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cytochrome P-450 Enzyme System</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ion Channels</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Receptors, G-Protein-Coupled</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Side effects / Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Structure-activity relationships</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vaz, Roy J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klabunde, Thomas</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028807336</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV043388752 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:36Z |
| institution | BVB |
| isbn | 9783527621460 3527621466 9783527621477 3527621474 1282784307 9781282784307 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028807336 |
| oclc_num | 264389537 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (xxiv, 480 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Wiley-VCH |
| record_format | marc |
| series2 | Methods and principles in medicinal chemistry |
| spelling | Antitargets prediction and prevention of drug side effects edited by Roy J. Vaz and Thomas Klabunde Weinheim Wiley-VCH ©2008 1 Online-Ressource (xxiv, 480 pages) txt rdacontent c rdamedia cr rdacarrier Methods and principles in medicinal chemistry v. 38 Includes bibliographical references and index This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that may be used as guidelines on how to improve drug development projects. With its large section on ADME-related effects, this is key knowledge for every drug developer Pharmaceutical Preparations / adverse effects Cytochrome P-450 Enzyme System Drug Design Drug Interactions Ion Channels Receptors, G-Protein-Coupled MEDICAL / Pharmacology bisacsh Medizin Drugs / Side effects Drugs / Side effects / Prevention Drug interactions Drug development Drugs / Structure-activity relationships Pharmazeutische Chemie (DE-588)4132158-3 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Arzneimittelnebenwirkung (DE-588)4003134-2 s Arzneimitteldesign (DE-588)4278218-1 s 2\p DE-604 Pharmazeutische Chemie (DE-588)4132158-3 s 3\p DE-604 Vaz, Roy J. Sonstige oth Klabunde, Thomas Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Antitargets prediction and prevention of drug side effects Pharmaceutical Preparations / adverse effects Cytochrome P-450 Enzyme System Drug Design Drug Interactions Ion Channels Receptors, G-Protein-Coupled MEDICAL / Pharmacology bisacsh Medizin Drugs / Side effects Drugs / Side effects / Prevention Drug interactions Drug development Drugs / Structure-activity relationships Pharmazeutische Chemie (DE-588)4132158-3 gnd Arzneimitteldesign (DE-588)4278218-1 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| subject_GND | (DE-588)4132158-3 (DE-588)4278218-1 (DE-588)4003134-2 (DE-588)4143413-4 |
| title | Antitargets prediction and prevention of drug side effects |
| title_auth | Antitargets prediction and prevention of drug side effects |
| title_exact_search | Antitargets prediction and prevention of drug side effects |
| title_full | Antitargets prediction and prevention of drug side effects edited by Roy J. Vaz and Thomas Klabunde |
| title_fullStr | Antitargets prediction and prevention of drug side effects edited by Roy J. Vaz and Thomas Klabunde |
| title_full_unstemmed | Antitargets prediction and prevention of drug side effects edited by Roy J. Vaz and Thomas Klabunde |
| title_short | Antitargets |
| title_sort | antitargets prediction and prevention of drug side effects |
| title_sub | prediction and prevention of drug side effects |
| topic | Pharmaceutical Preparations / adverse effects Cytochrome P-450 Enzyme System Drug Design Drug Interactions Ion Channels Receptors, G-Protein-Coupled MEDICAL / Pharmacology bisacsh Medizin Drugs / Side effects Drugs / Side effects / Prevention Drug interactions Drug development Drugs / Structure-activity relationships Pharmazeutische Chemie (DE-588)4132158-3 gnd Arzneimitteldesign (DE-588)4278218-1 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| topic_facet | Pharmaceutical Preparations / adverse effects Cytochrome P-450 Enzyme System Drug Design Drug Interactions Ion Channels Receptors, G-Protein-Coupled MEDICAL / Pharmacology Medizin Drugs / Side effects Drugs / Side effects / Prevention Drug interactions Drug development Drugs / Structure-activity relationships Pharmazeutische Chemie Arzneimitteldesign Arzneimittelnebenwirkung Aufsatzsammlung |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9783527621460 |
| work_keys_str_mv | AT vazroyj antitargetspredictionandpreventionofdrugsideeffects AT klabundethomas antitargetspredictionandpreventionofdrugsideeffects |